Skip to main content

Advertisement

Log in

Portfolio analysis and R&D decision making

  • From the Analyst's Couch
  • Published:

From Nature Reviews Drug Discovery

View current issue Sign up to alerts

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1: Influence of portfolio composition on success in pharmaceutical R&D.

References

  1. Blau, G. E., Pekny, J. F., Varma, V. A. & Bunch, P. R. Managing a portfolio of interdependent new product candidates in the pharmaceutical industry. J. Prod. Innov. Manag. 21, 227–245 (2004).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Scott Hinds.

Supplementary information

Supplementary information S1 (box)

Basis of analysis between portfolio size and probability of drug launches (PDF 186 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Evans, R., Hinds, S. & Hammock, D. Portfolio analysis and R&D decision making. Nat Rev Drug Discov 8, 189–190 (2009). https://doi.org/10.1038/nrd2744

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrd2744

  • Springer Nature Limited

This article is cited by

Navigation